Search Results - "Shord, SS"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Epigenetics and Oncology by Mummaneni, Padmaja, Shord, Stacy S.

    Published in Pharmacotherapy (01-05-2014)
    “…Epigenetic modifications play a critical role in the development of pediatric and adult cancers, contributing to the cumulative changes observed as normal…”
    Get full text
    Journal Article
  2. 2

    The Effect of Cyclophosphamide with and without Dexamethasone on Cytochrome P450 3A4 and 2B6 in Human Hepatocytes by LINDLEY, Celeste, HAMILTON, Geraldine, LECLUYSE, Edward L, MCCUNE, Jeannine S, FAUCETTE, Stephanie, SHORD, Stacy S, HAWKE, Roy L, HONGBING WANG, GILBERT, Darryl, JOLLEY, Summer, BINGFANG YAN

    Published in Drug metabolism and disposition (01-07-2002)
    “…The purpose of this study was to characterize the concentration-response effects of cyclophosphamide (CPA) with and without dexamethasone (DEX; 10 μM) on the…”
    Get full text
    Journal Article
  3. 3

    Evaluation of the Contribution of Cytochrome P450 3A4 to Human Liver Microsomal Bupropion Hydroxylation by FAUCETTE, Stephanie R, HAWKE, Roy L, SHORD, Stacy S, LECLUYSE, Edward L, LINDLEY, Celeste M

    Published in Drug metabolism and disposition (01-08-2001)
    “…The purpose of this investigation was to evaluate the role of cytochrome P450 (CYP) 3A4 in human liver microsomal bupropion (BUP) hydroxylation. Across the BUP…”
    Get full text
    Journal Article
  4. 4

    Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer by SHORD, Stacy S, FAUCETTE, Stephanie R, GILLENWATER, Heidi H, PESCATORE, Scott L, HAWKE, Roy L, SOCINSKI, Mark A, LINDLEY, Celeste

    Published in Cancer chemotherapy and pharmacology (01-04-2003)
    “…Gemcitabine administered at a fixed dose rate of 10 mg/m(2) per min has been reported to achieve plasma steady-state concentrations ranging from 10 to 20…”
    Get full text
    Journal Article
  5. 5

    Paclitaxel Decreases the Accumulation of Gemcitabine and its Metabolites in Human Leukemia Cells and Primary Cell Cultures by SHORD, Stacy S, CAMP, Joseph R, YOUNG, Lucy A. F

    Published in Anticancer research (01-11-2005)
    “…Background: We identified a drug-drug interaction between gemcitabine and paclitaxel in a clinical pharmacokinetic study. The purpose of the present study was…”
    Get full text
    Journal Article
  6. 6

    Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity by Shord, Stacy S, Bernard, Stephen A, Lindley, Celeste, Blodgett, Andrew, Mehta, Viral, Churchel, Mary Ann, Poole, Michael, Pescatore, Scott L, Luo, Feng R, Chaney, Stephen G

    Published in Anticancer research (01-07-2002)
    “…Both oxaliplatin and ormaplatin undergo biotransformation to Pt(dach)Cl2 with studies suggesting a predictive relationship between systemic exposure to…”
    Get more information
    Journal Article
  7. 7

    Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia by Shord, Stacy S, Hamilton, J.M., Cuellar, Sandra

    Published in Journal of oncology pharmacy practice (01-03-2008)
    “…Purpose. To discuss the clinical issues we addressed in the development of our institutional guidelines regarding the assessment of iron stores for cancer- and…”
    Get full text
    Journal Article
  8. 8

    Coagulation products and their uses by Shord, SS, Lindley, CM

    Published in American journal of health-system pharmacy (01-08-2000)
    “…The indications, pharmacokinetics, and therapeutic guidelines for available coagulation products are reviewed. Patients with hemophilia, von Willebrand's…”
    Get full text
    Journal Article
  9. 9